Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin.

Dae-Won LeeSae-Won Han Jeong Mo BaeHoon JangHyoki KimDuhee BangSeung-Yong JeongKyu Joo ParkGyeong Hoon KangTae-You Kim

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)

TMB-high is associated with better prognosis in patients with colorectal cancer treated with curative surgery followed by adjuvant fluoropyrimidine and oxaliplatin chemotherapy.

Keyphrases

early stage
minimally invasive
coronary artery bypass
risk factors
coronary artery disease
percutaneous coronary intervention